Ihre E-Mail wurde erfolgreich gesendet. Bitte prüfen Sie Ihren Maileingang.

Leider ist ein Fehler beim E-Mail-Versand aufgetreten. Bitte versuchen Sie es erneut.

Vorgang fortführen?

Exportieren
  • 1
    Online-Ressource
    Online-Ressource
    Basel :Karger,
    UID:
    almafu_BV036069376
    Umfang: 1 Online-Ressource (VIII, 187 Seiten) : , Diagramme.
    ISBN: 978-3-318-00723-7
    Serie: Monographs in virology Vol. 22
    Inhalt: Current cancer treatment approaches are characterized by very tight therapeutic indices and medical oncologists assign considerable care to treat adverse effects. A newly evolving concept in cancer therapy is the use of viruses. About 40 years ago initial trials based on the use of wild-type virus were not successful due to variable antitumoral effects and toxicity. The increase in our understanding of the molecular biology of malignant cells and viruses has now enabled researchers to design viruses that are capable of selectively destroying cancer cells and spare normal surrounding tissue. Oncolytic viruses either carry defined defects in their genomes which are specifically complemented by cancer cells, allowing their replication; or they are inherently selective for tumor cells. This book is the first to summarize the molecular principles of modern viral therapy for cancer. It reviews many of the replication-competent viruses currently being investigated for therapeutic use including herpes simplex virus, adenovirus, reovirus, parvovirus, vaccinia virus and Newcastle disease virus, and demonstrates how this approach is being translated to the clinic.Illustrating how virus-host interactions can be exploited for therapy, this book opens up new and promising perspectives for the treatment of cancer. It is therefore recommended reading for clinical investigators in the field of oncology, virologists, cancer immunologists and scientists working in regulatory agencies
    Anmerkung: summarizes the molecular principles of modern viral therapy for cancer
    Weitere Ausg.: Erscheint auch als Druck-Ausgabe ISBN 978-3-8055-7248-4
    Sprache: Englisch
    Fachgebiete: Medizin
    RVK:
    Schlagwort(e): Krebs ; Therapie ; Viren ; Replikation ; Aufsatzsammlung
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
  • 2
    Online-Ressource
    Online-Ressource
    Basel :Karger,
    UID:
    almahu_BV036069376
    Umfang: 1 Online-Ressource (VIII, 187 Seiten) : , Diagramme.
    ISBN: 978-3-318-00723-7
    Serie: Monographs in virology Vol. 22
    Inhalt: Current cancer treatment approaches are characterized by very tight therapeutic indices and medical oncologists assign considerable care to treat adverse effects. A newly evolving concept in cancer therapy is the use of viruses. About 40 years ago initial trials based on the use of wild-type virus were not successful due to variable antitumoral effects and toxicity. The increase in our understanding of the molecular biology of malignant cells and viruses has now enabled researchers to design viruses that are capable of selectively destroying cancer cells and spare normal surrounding tissue. Oncolytic viruses either carry defined defects in their genomes which are specifically complemented by cancer cells, allowing their replication; or they are inherently selective for tumor cells. This book is the first to summarize the molecular principles of modern viral therapy for cancer. It reviews many of the replication-competent viruses currently being investigated for therapeutic use including herpes simplex virus, adenovirus, reovirus, parvovirus, vaccinia virus and Newcastle disease virus, and demonstrates how this approach is being translated to the clinic.Illustrating how virus-host interactions can be exploited for therapy, this book opens up new and promising perspectives for the treatment of cancer. It is therefore recommended reading for clinical investigators in the field of oncology, virologists, cancer immunologists and scientists working in regulatory agencies
    Anmerkung: summarizes the molecular principles of modern viral therapy for cancer
    Weitere Ausg.: Erscheint auch als Druck-Ausgabe ISBN 978-3-8055-7248-4
    Sprache: Englisch
    Fachgebiete: Medizin
    RVK:
    Schlagwort(e): Krebs ; Therapie ; Viren ; Replikation ; Aufsatzsammlung
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
  • 3
    Online-Ressource
    Online-Ressource
    Basel :Karger,
    UID:
    edoccha_BV036069376
    Umfang: 1 Online-Ressource (VIII, 187 Seiten) : , Diagramme.
    ISBN: 978-3-318-00723-7
    Serie: Monographs in virology Vol. 22
    Inhalt: Current cancer treatment approaches are characterized by very tight therapeutic indices and medical oncologists assign considerable care to treat adverse effects. A newly evolving concept in cancer therapy is the use of viruses. About 40 years ago initial trials based on the use of wild-type virus were not successful due to variable antitumoral effects and toxicity. The increase in our understanding of the molecular biology of malignant cells and viruses has now enabled researchers to design viruses that are capable of selectively destroying cancer cells and spare normal surrounding tissue. Oncolytic viruses either carry defined defects in their genomes which are specifically complemented by cancer cells, allowing their replication; or they are inherently selective for tumor cells. This book is the first to summarize the molecular principles of modern viral therapy for cancer. It reviews many of the replication-competent viruses currently being investigated for therapeutic use including herpes simplex virus, adenovirus, reovirus, parvovirus, vaccinia virus and Newcastle disease virus, and demonstrates how this approach is being translated to the clinic.Illustrating how virus-host interactions can be exploited for therapy, this book opens up new and promising perspectives for the treatment of cancer. It is therefore recommended reading for clinical investigators in the field of oncology, virologists, cancer immunologists and scientists working in regulatory agencies
    Anmerkung: summarizes the molecular principles of modern viral therapy for cancer
    Weitere Ausg.: Erscheint auch als Druck-Ausgabe ISBN 978-3-8055-7248-4
    Sprache: Englisch
    Fachgebiete: Medizin
    RVK:
    Schlagwort(e): Krebs ; Therapie ; Viren ; Replikation ; Aufsatzsammlung
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
  • 4
    Online-Ressource
    Online-Ressource
    Basel : Karger
    UID:
    b3kat_BV036069376
    Umfang: 1 Online-Ressource (VIII, 187 Seiten) , Diagramme
    ISBN: 9783318007237
    Serie: Monographs in virology Vol. 22
    Inhalt: Current cancer treatment approaches are characterized by very tight therapeutic indices and medical oncologists assign considerable care to treat adverse effects. A newly evolving concept in cancer therapy is the use of viruses. About 40 years ago initial trials based on the use of wild-type virus were not successful due to variable antitumoral effects and toxicity. The increase in our understanding of the molecular biology of malignant cells and viruses has now enabled researchers to design viruses that are capable of selectively destroying cancer cells and spare normal surrounding tissue. Oncolytic viruses either carry defined defects in their genomes which are specifically complemented by cancer cells, allowing their replication; or they are inherently selective for tumor cells. This book is the first to summarize the molecular principles of modern viral therapy for cancer. It reviews many of the replication-competent viruses currently being investigated for therapeutic use including herpes simplex virus, adenovirus, reovirus, parvovirus, vaccinia virus and Newcastle disease virus, and demonstrates how this approach is being translated to the clinic.Illustrating how virus-host interactions can be exploited for therapy, this book opens up new and promising perspectives for the treatment of cancer. It is therefore recommended reading for clinical investigators in the field of oncology, virologists, cancer immunologists and scientists working in regulatory agencies
    Anmerkung: summarizes the molecular principles of modern viral therapy for cancer
    Weitere Ausg.: Erscheint auch als Druck-Ausgabe ISBN 978-3-8055-7248-4
    Sprache: Englisch
    Fachgebiete: Medizin
    RVK:
    Schlagwort(e): Krebs ; Therapie ; Viren ; Replikation ; Aufsatzsammlung
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
  • 5
    UID:
    gbv_1672335809
    Umfang: Online-Ressource
    Ausgabe: Karger eBooks Collection 1997-2009
    ISBN: 9783318007237
    Serie: Monographs in virology 22
    Inhalt: Current cancer treatment approaches are characterized by very tight therapeutic indices and medical oncologists assign considerable care to treat adverse effects. A newly evolving concept in cancer therapy is the use of viruses. About 40 years ago initial trials based on the use of wild-type virus were not successful due to variable antitumoral effects and toxicity. The increase in our understanding of the molecular biology of malignant cells and viruses has now enabled researchers to design viruses that are capable of selectively destroying cancer cells and spare normal surrounding tissue. Oncolytic viruses either carry defined defects in their genomes which are specifically complemented by cancer cells, allowing their replication; or they are inherently selective for tumor cells. This book is the first to summarize the molecular principles of modern viral therapy for cancer. It reviews many of the replication-competent viruses currently being investigated for therapeutic use including herpes simplex virus, adenovirus, reovirus, parvovirus, vaccinia virus and Newcastle disease virus, and demonstrates how this approach is being translated to the clinic.Illustrating how virus-host interactions can be exploited for therapy, this book opens up new and promising perspectives for the treatment of cancer. It is therefore recommended reading for clinical investigators in the field of oncology, virologists, cancer immunologists and scientists working in regulatory agencies
    Anmerkung: Includes bibliographical references and index , ""Contents ""; ""Introduction""; ""Replication-Competent Herpes Simplex Virus Vectors for Cancer Therapy""; ""dl3520 (ONYX-035) as an Antitumor Agent""; ""Attenuated Replication-CompetentAdenoviruses (ARCA©) for ProstateCancer: CV706 to CV787""; ""Reovirus as a Potential Anticancer Therapeutic""; ""Autonomous Parvoviruses""; ""Vaccinia Virus""; ""Replication-Competent, Oncolytic Newcastle Disease Virus for Cancer Therapy""; ""Subject Index""
    Weitere Ausg.: ISBN 9783318007237
    Sprache: Englisch
    Schlagwort(e): Krebs ; Therapie ; Viren ; Replikation
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
  • 6
    Buch
    Buch
    Basel [u.a.] :Karger,
    UID:
    almafu_BV014038237
    Umfang: VIII, 187 S. : graph. Darst.
    ISBN: 3-8055-7248-4
    Serie: Monographs in virology 22
    Sprache: Englisch
    Fachgebiete: Medizin
    RVK:
    Schlagwort(e): Krebs ; Therapie ; Viren ; Replikation ; Krebs ; Retroviren ; Tumorhemmstoff ; Krebs ; Retroviren ; Lokoregionäre Chemotherapie ; Aufsatzsammlung
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
  • 7
    Online-Ressource
    Online-Ressource
    Basel ; : Karger,
    UID:
    edocfu_9958058470302883
    Umfang: 1 online resource (195 p.)
    ISBN: 3-318-00723-4
    Serie: Monographs in virology, vol. 22
    Inhalt: Current cancer treatment approaches are characterized by very tight therapeutic indices and medical oncologists assign considerable care to treat adverse effects. A newly evolving concept in cancer therapy is the use of viruses. About 40 years ago initial trials based on the use of wild-type virus were not successful due to variable antitumoral effects and toxicity. The increase in our understanding of the molecular biology of malignant cells and viruses has now enabled researchers to design viruses that are capable of selectively destroying cancer cells and spare normal surrounding tissue. Oncolytic viruses either carry defined defects in their genomes which are specifically complemented by cancer cells, allowing their replication; or they are inherently selective for tumor cells. This book is the first to summarize the molecular principles of modern viral therapy for cancer. It reviews many of the replication-competent viruses currently being investigated for therapeutic use including herpes simplex virus, adenovirus, reovirus, parvovirus, vaccinia virus and Newcastle disease virus, and demonstrates how this approach is being translated to the clinic. Illustrating how virus-host interactions can be exploited for therapy, this book opens up new and promising perspectives for the treatment of cancer. It is therefore recommended reading for clinical investigators in the field of oncology, virologists, cancer immunologists and scientists working in regulatory agencies.
    Anmerkung: Description based upon print version of record. , ""Contents ""; ""Introduction""; ""Replication-Competent Herpes Simplex Virus Vectors for Cancer Therapy""; ""dl3520 (ONYX-035) as an Antitumor Agent""; ""Attenuated Replication-CompetentAdenoviruses (ARCA©) for ProstateCancer: CV706 to CV787""; ""Reovirus as a Potential Anticancer Therapeutic""; ""Autonomous Parvoviruses""; ""Vaccinia Virus""; ""Replication-Competent, Oncolytic Newcastle Disease Virus for Cancer Therapy""; ""Subject Index"" , English
    Weitere Ausg.: ISBN 3-8055-7248-4
    Sprache: Englisch
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
  • 8
    UID:
    almafu_BV002763133
    Umfang: 128 S. : graph. Darst.
    Anmerkung: Frankfurt (Main), Univ., Diss., 1989
    Sprache: Deutsch
    Schlagwort(e): Hochschulschrift
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
  • 9
    UID:
    gbv_1018360263
    ISSN: 1476-4687
    In: Nature, London [u.a.] : Nature Publ. Group, 1869, 555(2018), 7697, Seite 469-474, 1476-4687
    In: volume:555
    In: year:2018
    In: number:7697
    In: pages:469-474
    Sprache: Englisch
    Mehr zum Autor: Witt, Olaf 1965-
    Mehr zum Autor: Sahm, Felix 1984-
    Mehr zum Autor: Weller, Michael 1962-
    Mehr zum Autor: Schrimpf, Daniel 1984-
    Mehr zum Autor: Capper, David 1979-
    Mehr zum Autor: Hans, Volkmar
    Mehr zum Autor: Benner, Axel 1959-
    Mehr zum Autor: Pfister, Stefan 1974-
    Mehr zum Autor: Kulozik, Andreas 1959-
    Mehr zum Autor: Hartmann, Christian
    Mehr zum Autor: Milde, Till
    Mehr zum Autor: Reifenberger, Guido
    Mehr zum Autor: Sill, Martin 1982-
    Mehr zum Autor: Blümcke, Ingmar 1965-
    Mehr zum Autor: Herold-Mende, Christel
    Mehr zum Autor: Lichter, Peter 1957-
    Mehr zum Autor: Sturm, Dominik 1983-
    Mehr zum Autor: Witt, Hendrik
    Mehr zum Autor: Wick, Wolfgang 1970-
    Mehr zum Autor: Zapatka, Marc 1974-
    Mehr zum Autor: Prinz, Marco 1970-
    Mehr zum Autor: Selt, Florian 1984-
    Mehr zum Autor: Temming, Petra 1976-
    Mehr zum Autor: Hovestadt, Volker
    Mehr zum Autor: Acker, Till 1969-
    Mehr zum Autor: Hänggi, Daniel 1970-
    Mehr zum Autor: Stichel, Damian
    Mehr zum Autor: Platten, Michael 1971-
    Mehr zum Autor: Reuss, David 1976-
    Mehr zum Autor: Unterberg, Andreas
    Mehr zum Autor: Bendszus, Martin
    Mehr zum Autor: Debus, Jürgen 1964-
    Mehr zum Autor: Staszewski, Ori 1979-
    Mehr zum Autor: Coras, Roland 1980-
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
  • 10
Schließen ⊗
Diese Webseite nutzt Cookies und das Analyse-Tool Matomo. Weitere Informationen finden Sie auf den KOBV Seiten zum Datenschutz